drugset / Trial / NCT05312190
Clinical and Basic Researches Related to ZhenQi Buxue Oral Liquid in Treating Menstrual Disorders
Unknown
330 enrolled
Peking Union Medical College Hospital
Chongqing Medical University No.1 Affiliated Hospital · collabGuangzhou Women and Children's Medical Center · collabLiuzhou Maternity and Child Healthcare Hospital · collabMaternal and Child Health Hospital of Hubei Province · collabSecond Affiliated Hospital of Nanchang University · collabThe Second Hospital of Hebei Medical University · collabWest China Second University Hospital · collabZhejiang University · collabZhongda Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a national multicenter prospective, randomized, controlled trial, which evaluates Zhenqi Buxue Oral Liquid，Progesterone Capsules and the addition of Zhenqi Buxue Oral Liquid to Progesterone Capsules in the treatment of menstrual disorders in adults women. One third of participanta will receive Zhenqi Buxue Oral Liquid, one third of participanta will receive Progesterone Capsules, and the another third will receive Zhenqi Buxue Oral Liquid and Progesterone Capsules in combination.
Timeline
- Start
- 2022-03-15
- Primary completion
- 2022-12-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Progesterone | Other / unclassified | 200 mg | Oral |
| Subject | ZhenQi BuXue KouFuYe | Unknown | 10 ml | Oral |